Literature DB >> 11860577

Acquired leukoderma in congenital pigmented nevus associated with vitiligo-like depigmentation.

Peter H Itin1, Stephan Lautenschlager.   

Abstract

We report a 6-year-old boy who developed depigmentation within a congenital melanocytic nevus at the age of 3 years. During the following months a halo phenomenon and vitiligo-like lesions distant from the nevus appeared. A thorough search for malignant melanoma was negative. A second patient, a 45-year-old woman, had a large congenital nevus on the trunk with marked satellitosis. At the age of 20 years, partial regression of the large nevus occurred and, in addition, halos developed around almost all smaller nevi. Repeated searches for associated malignant melanoma were negative. We review the rare cases of halo congenital nevi and emphasize that depigmentation is not necessarily associated with malignant degeneration.

Entities:  

Mesh:

Year:  2002        PMID: 11860577     DOI: 10.1046/j.1525-1470.2002.00028.x

Source DB:  PubMed          Journal:  Pediatr Dermatol        ISSN: 0736-8046            Impact factor:   1.588


  4 in total

1.  Development of Halo Nevus Around Nevus Spilus as a Central Nevus, and the Concurrent Vitiligo.

Authors:  Yoon Young Kim; Mi Yeon Kim; Tae Yoon Kim
Journal:  Ann Dermatol       Date:  2008-12-31       Impact factor: 1.444

2.  Acrofacial Vitiligo Following Halo Formation around Congenital Melanocytic Naevi.

Authors:  Lalit Kumar Gupta; Chesta Agrawal; Ashok Kumar Khare; Asit Mittal; Sharad Mehta; Manisha Balai
Journal:  Indian J Dermatol       Date:  2016 Nov-Dec       Impact factor: 1.494

Review 3.  Giant congenital melanocytic nevus.

Authors:  Ana Carolina Leite Viana; Bernardo Gontijo; Flávia Vasques Bittencourt
Journal:  An Bras Dermatol       Date:  2013 Nov-Dec       Impact factor: 1.896

4.  Spontaneous Involution of Congenital Melanocytic Nevus With Halo Phenomenon.

Authors:  Noo Ri Lee; Hee-Chul Chung; Hannah Hong; Jin Wook Lee; Sung Ku Ahn
Journal:  Am J Dermatopathol       Date:  2015-12       Impact factor: 1.533

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.